Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2009 Jun;47(6):1902-5.
doi: 10.1128/JCM.02304-08. Epub 2009 Apr 8.

Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp

Affiliations
Multicenter Study

Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp

Jana M Swenson et al. J Clin Microbiol. 2009 Jun.

Abstract

This report describes the results of an 11-laboratory study to determine if a cefoxitin broth microdilution MIC test could predict the presence of mecA in staphylococci. Using breakpoints of < or = 4 microg/ml for mecA-negative and > or = 6 or 8 microg/ml for mecA-positive isolates, sensitivity and specificity based on mecA or presumed mecA for Staphylococcus aureus at 18 h of incubation were 99.7 to 100% in three cation-adjusted Mueller-Hinton broths tested. For coagulase-negative strains at 24 h of incubation, breakpoints of < or = 2 microg/ml for mecA-negative and > or = 4 microg/ml for mecA-positive isolates gave sensitivity and specificity of 94 to 99% and 69 to 80%, respectively.

PubMed Disclaimer

References

    1. Bannerman, T. L., and S. J. Peacock. 2007. Staphylococcus, Micrococcus and other catalase-positive cocci. .In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed., vol. 1. ASM Press, Washington, DC.
    1. Clinical and Laboratory Standards Institute/NCCLS. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Felten, A., B. Grandry, P. H. Lagrange, and I. Casin. 2002. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J. Clin. Microbiol. 402766-2771. - PMC - PubMed
    1. Hindler, J., K. Ward, D. Buckner, L. B. Reller, P. C. Schreckenberger, J. Tjhio, K. Sei, and L. M. Mann. 2008. Multicenter evaluation of a MicroScan dried overnight cefoxitin screen in combination with oxacillin MIC results for detection of β-lactam resistance in staphylococci, abstr. C-015, Abstr. 108th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
    1. Join-Lambert, O. F., S. Clauser, C. Guillet, J.-P. Jais, E. Abachin, G. Quesnes, E. Carbonnelle, A. Le Monnier, J.-R. Zahar, S. Kayal, P. Berche, and A. Ferroni. 2007. Comparison of cefoxitin and moxalactam 30 μg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci. J. Antimicrob. Chemother. 59763-766. - PubMed

MeSH terms

Substances